ATXN2 and amyotrophic lateral sclerosis: This work showed that an increase in the length of a polyQ repeat in ATXN2 (from 22 normal to 27–33 glutamines in ALS) is significantly associated with enhanced risk for developing ALS (Elden et al., 2010).